Amrutanjan Health Care Limited
AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company is more than 120 years old and is into OTC products in the segments of pain management, women's hygiene, and packaged fruit juice drink.
What Amrutanjan files
- Others41
- Dividend/Bonus14
- Important14
- PPTs7
- Board Meeting6
- Results4
AHCL's board approved Q2 & H1 FY26 standalone results. Revenue from operations for Q2 rose 7.1% YoY to ₹117.70 Cr. Net profit surged 18.3% YoY to ₹13.96 Cr, with EPS at ₹4.83. For H1 FY26, revenue increased 9.4% to ₹211.75 Cr, and net profit jumped 35.7% to ₹22.27 Cr. This...
Amrutanjan Health Care Ltd (AMRUTANJAN) has posted strong financial results for the quarter ended June 30, 2025. 1. **Revenue Performance:** Total revenue from operations increased 12.31% year-over-year (YoY) to INR 94.05 Cr. Growth was primarily fueled by the OTC Products segment, which saw a robust rise, and the Women's Hygiene...
Amrutanjan Health Care Limited has announced a board meeting on May 15, 2025, approving the financial results for the quarter and half-year. 1) Revenue Performance: Total revenue for the year was INR 451.82 Cr, up 7.2% YoY from INR 421.23 Cr. Growth was mainly driven by the OTC Products segment...
Amrutanjan Health Care Limited has announced a board meeting regarding its financial results for the quarter and nine months ended December 31, 2024. The company reported revenue from operations of ₹12,275.15 crore and a profit after tax of ₹1,924.57 crore for the quarter. Total income reached ₹12,711.18 crore, indicating solid...